ANTIPLATELET THERAPY CONTROL: CREDIBILITY GAP OR SEARCH FOR NEW DECISIONS?

ANTIPLATELET THERAPY CONTROL: CREDIBILITY GAP OR SEARCH FOR NEW DECISIONS?

Show other versions (1)

The review presents recent data on the usage of platelet functional tests in patients with ischemic heart disease after percutaneous coronary intervention and its contribution to antiplatelet therapy personalization and cardiovascular events frequency reduction.

Bibliographic Details
Main Authors:	Yu. I. Grinshtein, A. A. Kosinova, I. Yu. Grinshtein
Format:	Article
Language:	English
Published:	Stolichnaya Izdatelskaya Kompaniya 2015-09-01
Series:	Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:	platelet reactivity antiplatelet therapy percutaneous coronary intervention
Online Access:	https://www.rpcardio.com/jour/article/view/294

Similar Items

ANTIPLATELET THERAPY CONTROL: CREDIBILITY GAP OR SEARCH FOR NEW DECISIONS?
by: Yu. I. Grinshtein, et al.
Published: (2015-09-01)

Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
by: Verheugt Freek WA, et al.
Published: (2001-05-01)

ANTIPLATELET THERAPY IN PROPHILAXY OF NEGATIVE CARDIOVASCULAR EVENTS AFTER CORONARY REVASCULARIZATION. IS THERE A CONSENSUS?
by: Yu. I. Grinschtein, et al.
Published: (2014-06-01)

PLATELET FUNCTION TEST FOR THE ASSESSMENT OF THROMBOSIS AND BLEEDING RISK IN CHD PATIENTS TAKING ANTIPLATELET MEDICATIONS
by: A. L. Komarov, et al.
Published: (2015-03-01)

Dual antiplatelet therapy and non-cardiac surgery: evolving issues and anesthetic implications
by: Jong Wook Song, et al.
Published: (2017-02-01)

Individualized Antiplatelet Therapy: A Long Way to Go
by: Ya-Ling Han
Published: (2018-01-01)

The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention
by: A. S. Tereshchenko, et al.
Published: (2019-05-01)

Long term dual antiplatelet therapy after myocardial infarction: retrospective analysis in an outpatient population
by: Gennaro Ratti, et al.
Published: (2021-09-01)

Optimizing the Duration of Dual Antiplatelet Therapy After Implantation of Drug-eluting Coronary Stents
by: Ying Shen, et al.
Published: (2015-01-01)

Individualized dual antiplatelet therapy based on platelet function testing in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials
by: Yijiang Zhou, et al.
Published: (2017-06-01)

Modern Antiplatelet Therapy for Percutaneous Coronary Intervention. How to Make the Right Choice?
by: T. M. Uskach, et al.
Published: (2020-12-01)

Choice of dual antiplatelet therapy in patients with acute coronary syndrome after percutaneous coronary intervention
by: A. N. Golosova, et al.
Published: (2020-08-01)

Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
by: Goto, Koji
Published: (2015)

Stent thrombosis associated with drug eluting stents on addition of cilostazol to the standard dual antiplatelet therapy following percutaneous coronary intervention: a systematic review and meta-analysis of published randomized controlled trials
by: Feng Huang
Published: (2018-06-01)

Validating Utility of Dual Antiplatelet Therapy Score in a Large Pooled Cohort From 3 Japanese Percutaneous Coronary Intervention Studies
by: Yoshikawa, Yusuke
Published: (2020)

MicroRNA as Potential Biomarkers of Platelet Function on Antiplatelet Therapy: A Review
by: Pamela Czajka, et al.
Published: (2021-04-01)

Prognosis of Atrial Fibrillation Patients Undergoing PCI According to Anticoagulants and Antiplatelet Agents
by: Gwang-Seok Yoon, et al.
Published: (2021-07-01)

ANTIPLATELET THERAPY OF ACUTE CORONARY SYNDROME: CURRENT CAPAB ILITIES
by: E. V. Konstantinova, et al.
Published: (2018-07-01)

Molecular and metabolic characteristics of changes in the platelet sensitivity to antiplatelet therapy in patients with coronary artery disease before and after coronary artery bypass grafting
by: M. D. Goncharov, et al.
Published: (2021-07-01)

Cangrelor Use in Routine Practice: A Two-Center Experience
by: Niels M. R. van der Sangen, et al.
Published: (2021-06-01)

THE SIGNIFICANCE OF PLATELET FUNCTIONAL ACTIVITY TESTING IN THE PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS RECEIVING ANTIPLATELET THERAPY
by: D. A. Andreev
Published: (2015-09-01)

Thrombin Generation as a Method to Identify the Risk of Bleeding in High Clinical-Risk Patients Using Dual Antiplatelet Therapy
by: C. P. D. M. de Breet, et al.
Published: (2021-06-01)

Duration of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome Treated With New Generation Stents: A Meta-Analysis of Randomized Controlled Trials
by: Wen-Jiao Zhang, et al.
Published: (2021-02-01)

Obstructive Sleep Apnea Affecting Platelet Reactivity in Patients Undergoing Percutaneous Coronary Intervention
by: Xiao-Min Jiang, et al.
Published: (2018-01-01)

Duration of antiplatelet therapy cessation before coronary artery bypass surgery: Relation with platelet count
by: Sushil Prakash Ambesh
Published: (2015-07-01)

Efficacy and Safety of Long-Term and Short-Term Dual Antiplatelet Therapy: A Meta-Analysis of Comparison between Asians and Non-Asians
by: You-Jeong Ki, et al.
Published: (2020-02-01)

Balloon coronary angioplasty and parenteral antiplatelet therapy for intraoperative myocardial infarction during general surgery: An attempt to balance benefits and risks - a case report
by: Nešković Vojislava C., et al.
Published: (2020-01-01)

Efficacy and Safety of Very Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stents Implantation for Acute Coronary Syndrome: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
by: Peng-Yu Zhong, et al.
Published: (2021-09-01)

Clinical Outcomes of Very Short Term Dual Antiplatelet Therapy in Patients With or Without Diabetes Undergoing Second-Generation Drug-Eluting Stents: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
by: Xi-Ying Liang, et al.
Published: (2021-07-01)

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: What is new?
by: Zeki Öngen
Published: (2018-01-01)

The Effect of Diabetes on Prognosis Following Myocardial Infarction Treated with Primary Angioplasty and Potent Antiplatelet Therapy
by: Stanislav Simek, et al.
Published: (2020-08-01)

DUAL ANTIPLATELET THERAPY IN THE REAL CLINICAL PRACTICE
by: G. N. Guseva, et al.
Published: (2015-09-01)

Antiplatelet Therapy Discontinuation and the Risk of Serious Cardiovascular Events after Coronary Stenting: Observations from the CREDO-Kyoto Registry Cohort-2
by: Watanabe, Hirotoshi
Published: (2016)

The relationship between the combined use of various proton pump inhibitors with antiplatelet drugs and the risk of cardiovascular complications
by: O D Ostroumova, et al.
Published: (2019-08-01)

Analysis of Platelet Function from Thromboelastography Examination in Patients with Single and Multiple Antiplatelet Therapy after Percutaneous Coronary Intervention at Dr. Saiful Anwar Malang
by: Sasmojo Widito, et al.
Published: (2020-04-01)

Difficulties in evaluating the efficacy of antiplatelet therapy in clinical practice
by: L I Buryachkovskaya, et al.
Published: (2009-05-01)

Acute coronary syndrome: pathogenesis, diagnosis, treatment, rehabilitation (lecture 2)
by: N. B Perepech
Published: (2016-06-01)

Newer P2Y12 Inhibitors: How Does the Interventional Cardiologist Choose?
by: David M. Shavelle
Published: (2016-09-01)

Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome
by: Wilbert Bor, et al.
Published: (2020-06-01)

Timing of dual antiplatelet therapy in acute coronary syndrome: a problem of coronary artery bypass grafting accessibility for patients
by: T. S. Golovina, et al.
Published: (2020-09-01)

Cannot write session to /tmp/vufind_sessions/sess_cc7mf7kkr1m7in357nsqkbegj3